Who
Charles Bruce Green
Director
Company insider
Files Form 4 as: Director, Humacyte.
In numbers
- Trades disclosed
- 13
- Buys
- 1
- Sells
- 0
- Bought
- $7,740
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 15 Sep 2022
- Last trade
- 11 Jun 2026
- Last filed
- 12 Jun 2026
Companies traded
Activity over time
1 Apr 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Jun 2026filed 12 Jun 2026 | HUMA Humacyteoption or derivative · Biotechnology | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 11 Jun 2026filed 12 Jun 2026 | HUMA Humacyteoption or derivative · Biotechnology | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 12 Jun 2025filed 16 Jun 2025 | HUMA Humacyteoption or derivative · Biotechnology | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 8 Apr 2025filed 8 Apr 2025 | HUMA HumacyteBiotechnology | SEC FORM 4 Bought | $7,7406,000 at $1.29 | filing |
| 13 Sep 2024filed 16 Sep 2024 | HUMA Humacyteoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,200 at $0.00 | filing |
| 13 Sep 2024filed 16 Sep 2024 | HUMA HumacyteBiotechnology | SEC FORM 4 Code M | $4,9081,200 at $4.09 | filing |
| 13 Jun 2024filed 17 Jun 2024 | HUMA Humacyteoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 20 May 2024filed 21 May 2024 | HUMA Humacyteoption or derivative · Biotechnology | SEC FORM 4 Code M | —600 at $0.00 | filing |
| 20 May 2024filed 21 May 2024 | HUMA HumacyteBiotechnology | SEC FORM 4 Code M | $2,454600 at $4.09 | filing |
| 17 May 2024filed 20 May 2024 | HUMA Humacyteoption or derivative · Biotechnology | SEC FORM 4 Code M | —600 at $0.00 | filing |
| 17 May 2024filed 20 May 2024 | HUMA HumacyteBiotechnology | SEC FORM 4 Code M | $2,454600 at $4.09 | filing |
| 15 Jun 2023filed 16 Jun 2023 | HUMA Humacyteoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,500 at $0.00 | filing |
| 15 Sep 2022filed 19 Sep 2022 | HUMA Humacyteoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,000 at $0.00 | filing |
News
Humacyte Provides Commercial Update and Highlights Rapid Acceleration of Symvess Adoption by HospitalsHUMA · manilatimes.net · 15 Oct 2026
0 headlines in the last 90 days name Charles Bruce Green; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.